Our work on NMDAR1A- and IL-10-centered neuroimmune targeting in chronic pancreatitis has been selected for oral presentation in the Best Abstracts · Chronic Pancreatitis session at the EPC / IAP Joint Meeting 2026 in Istanbul.
Imperion-linked pancreatic disease research will be represented at the EPC / IAP Joint Meeting 2026 in Istanbul through an oral presentation selected for the Best Abstracts · Chronic Pancreatitis session.
The selected work focuses on NMDAR1A- and IL-10-centered neuroimmune targeting in chronic pancreatitis, exploring how pain biology, immune regulation and tissue pathology intersect in chronic pancreatic disease.
This recognition reflects the growing importance of neuroimmune mechanisms in translational pancreatology and supports our broader direction of developing mechanism-guided strategies for complex inflammatory and cancer-associated diseases.